在高输出心力衰竭中死亡率的侵入性血液动力学预测因素
Satoshi Miyashita1, Raquel Lamarche2, Rana Abualsaud3
1Department of Critical Care Medicine, Integrated Hospital Care Institute, Cleveland Clinic, Cleveland, Ohio; Department of Cardiovascular Medicine Heart, Vascular, and Thoracic Institute Cleveland Clinic Foundation, Cleveland, Ohio; Department of General Medicine, Juntendo University Faculty of Medicine, Japan.
Journal of cardiac failure
|November 13, 2025
概括
高输出心力衰竭 (HOHF) 患者心脏指数 (CI) 高,死亡风险更高. 血液动力学评估,特别是CI,对于风险分层和HOHF的潜在治疗改善至关重要.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
- 临床研究 临床研究
背景情况:
- 高输出心力衰竭 (HOHF) 的特点是心脏输出量升高和体积过载.
- 关于HOHF侵袭性血液动力学和临床结果之间的关系的数据有限.
研究的目的:
- 为了研究关键的侵入性血液动力学措施与HOHF患者的全因死亡率之间的关联.
主要方法:
- 对248名接受右心导管治疗的成年患者进行了回顾性分析,其心脏指数 (CI) 和填充压力升高.
- 随访时间中位数为3.3年,主要终点为全因死亡率.
- 多变量分析调整为人口统计学,并发病和血液动力学变量.
主要成果:
- 心脏指数 (CI) 升高是死亡率最强的预测因素 (HR 1.87,P < 0.001).
- 其他死亡预测因素包括右心房压 (HR 1.30) 和平均动脉压 (HR 0.97).
- 系统性血管抵抗与死亡率 (HR 0.70) 相反相关.
结论:
- 升高的CI是HOHF中死亡率的最重要的血液动力学预测因子.
- 血液动力学评估有助于对HOHF患者的风险分层.
- 针对血液动力学的疗法可能会改善这一群体的治疗结果.
相关概念视频
Heart Failure II: Pathophysiology
695
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
695
Pathophysiology of Heart Failure
2.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.7K
Heart Failure I: Introduction
671
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
671
Heart Failure V: Medical Management
207
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
207
Heart Failure VII: Nursing Interventions
404
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
404
Heart Failure VI: Adjunct Therapies
243
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
243


